Interview: Different perspectives on how to define success in CLL
Interview: Different perspectives on how to define suc
Issues in the management of CLL patients from an international point of view
Issues in the management of CLL patients from an
CLL treatment in the real world: insights from across the globe
CLL treatment in the real world: insights from a
Overcoming resistance to targeted inhibitors
Overcoming resistance to targeted inhibitors
Long-term results and other findings from clinical trials
Long-term results and other findings from clinical tri
Continuous BTK inhibition and combination regimens: present and future
Continuous BTK inhibition and combination regime
Preface – iwCLL 2023
Preface – iwCLL 2023 © author's own – Kiyomi Mashi
Updates on BTK- and Bcl-2–targeted treatment in various B-cell malignancies
Updates on BTK- and Bcl-2–targeted treatment in variou
DLBCL: treatment of elderly patients and relapsed disease
DLBCL: treatment of elderly patients and relapsed dise
Waldenström macroglobulinemia: findings from ASPEN and BRUIN
Waldenström macroglobulinemia: findings from ASPEN and
